…
Ajinomoto Co., Inc. engages in the seasonings and foods, frozen foods, and healthcare and other businesses in Japan and internationally. The Seasonings and Foods segment offers sauces and seasoning products under the AJI-NO-MOTO, HON-DASHI, Cook Do, Ajinomoto KK Consommé, Pure Select Mayonnaise, Ros Dee, Masako, Aji-ngon, Sazón, Sajiku, and CRISPY FRY names. This segment also provides instant noodles under the Knorr Cup Soup and YumYum names; coffee beverages under the Birdy and Blendy brands; powdered drink under the Birdy 3in1 name; MAXIM brand products; A Little Luxury Coffee Shop brand products and various gifts, office drinks, cup vending machines, and tea dispensers, etc. The Frozen Foods segment offers Gyoza dumplings, rice dishes, noodles, sweets, shumai, processed chicken, and other products. The Healthcare and Other segment provides amino acids for applications in various industries, such as pharmaceuticals and foods; contract development and manufacturing services for pharmaceutical intermediates and active ingredients, and sterile preparations. This segment also offers Ajinomoto Build-up Film, an interlayer insulating material for semiconductor packages; functional materials under the Plainset names; AFTINNOVA, such as activated carbon, release paper, etc.; feed amino acids, sports nutrition under the brand Aminovital, personal care materials under the brand Amisoft, amino acid-based makeup oil under the brand Eldew, and powder under the brand Amihope, medical foods, and agricultural services, etc. Ajinomoto Co., Inc. was founded in 1909 and is headquartered in Tokyo, Japan.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Ajinomoto Co., Inc. is a Tokyo-based global food and amino-acid company selling seasonings, frozen foods and specialty amino acids for food, feed and clinical nutrition. Long-term growth could be driven by rising demand for convenience and healthier foods in Asia, expansion of specialty amino-acid and clinical nutrition products, and innovation in sodium-reduction and umami solutions. It appears positioned with diversified revenue streams, established brands and R&D capabilities that may support steady cash generation.
Key risks include commodity and currency exposure, strong competition, regulatory and food-safety compliance across markets, and execution or supply-chain challenges.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Income before tax | 108330.00M | 142043.00M | 140033.00M | 122472.00M | 98320.00M |
| Minority interest | -10501.00M | -14911.00M | -6104.00M | -4503.00M | 47589.00M |
| Net income | 70272.00M | 87121.00M | 94065.00M | 75725.00M | 59416.00M |
| Selling general administrative | 366854.00M | 339730.00M | 313505.00M | 281124.00M | 268499.00M |
| Gross profit | 550764.00M | 511448.00M | 470387.00M | 425897.00M | 406219.00M |
| Reconciled depreciation | 86461.00M | 78298.00M | 71820.00M | 66234.00M | 63045.00M |
| Ebit | - | - | - | 121918.00M | 105844.00M |
| Ebitda | - | - | 226847.00M | 197674.00M | 168066.00M |
| Operating income | 107656.00M | 141953.00M | 144602.00M | 123587.00M | 99806.00M |
| Other operating expenses | - | - | - | -2017.00M | 5976.00M |
| Interest expense | 14431.00M | 12414.00M | 14994.00M | 8968.00M | 6701.00M |
| Tax provision | 27556.00M | 40011.00M | 39863.00M | 42244.00M | 32040.00M |
| Interest income | 8792.00M | 7775.00M | 6099.00M | 6868.00M | 3900.00M |
| Net interest income | -5639.00M | -4639.00M | -8895.00M | -2100.00M | -2801.00M |
| Income tax expense | - | - | - | 42244.00M | 32040.00M |
| Total revenue | 1530556.00M | 1439231.00M | 1359115.00M | 1149370.00M | 1071453.00M |
| Total operating expenses | 1422900.00M | 1297278.00M | 1214512.00M | 1025782.00M | 971647.00M |
| Cost of revenue | 979792.00M | 927783.00M | 888727.00M | 723472.00M | 665234.00M |
| Net income from continuing ops | 80773.00M | 102032.00M | 100170.00M | 80228.00M | 66280.00M |
| Net income applicable to common shares | - | - | - | 75725.00M | 59416.00M |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Total assets | 1721131.00M | 1768371.00M | 1511734.00M | 1457060.00M | 1431289.00M |
| Intangible assets | 92168.00M | 97810.00M | 65916.00M | 68309.00M | 72201.00M |
| Other current assets | 27603.00M | 20254.00M | 24238.00M | 24378.00M | 33255.00M |
| Total liab | 907858.00M | 883923.00M | 688766.00M | 717316.00M | 763443.00M |
| Total stockholder equity | 746804.00M | 815074.00M | 768676.00M | 686909.00M | 620257.00M |
| Other current liab | 9025.00M | 15048.00M | 15405.00M | 36554.00M | 31548.00M |
| Common stock | - | - | - | 79863.00M | 79863.00M |
| Capital stock | 79863.00M | 79863.00M | 79863.00M | 79863.00M | 79863.00M |
| Retained earnings | 590517.00M | 657782.00M | 652307.00M | 616286.00M | 608031.00M |
| Other liab | - | - | - | 78328.00M | 98334.00M |
| Good will | 117940.00M | 139879.00M | 92114.00M | 99839.00M | 96024.00M |
| Other assets | - | - | - | 7020.00M | 14540.00M |
| Cash | 164776.00M | 171537.00M | 132777.00M | 151454.00M | 181609.00M |
| Total current liabilities | 384588.00M | 501569.00M | 339644.00M | 324631.00M | 323736.00M |
| Net debt | 290577.00M | 270957.00M | 155787.00M | 162454.00M | 168815.00M |
| Short long term debt | 39146.00M | 188270.00M | 49320.00M | 42627.00M | 58905.00M |
| Other stockholder equity | - | - | - | -7869.00M | -66173.00M |
| Property plant equipment | - | - | - | 522312.00M | 486443.00M |
| Total current assets | 701298.00M | 709632.00M | 615537.00M | 581419.00M | 585169.00M |
| Net tangible assets | - | - | - | 518761.00M | 452032.00M |
| Short term investments | 17990.00M | 22650.00M | 12312.00M | 17810.00M | 12078.00M |
| Net receivables | 174136.00M | 185564.00M | 163714.00M | 168421.00M | 169563.00M |
| Long term debt | 416207.00M | 254224.00M | 239244.00M | 271281.00M | 291519.00M |
| Inventory | 286952.00M | 287122.00M | 269822.00M | 219356.00M | 188664.00M |
| Accounts payable | 240614.00M | 231979.00M | 197981.00M | 199908.00M | 188452.00M |
| Non currrent assets other | 42729.00M | 42442.00M | 19059.00M | 11052.00M | 11092.00M |
| Non current assets total | 1019833.00M | 1058738.00M | 896197.00M | 875641.00M | 846119.00M |
| Breakdown | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
| Investments | 15823.00M | -2354.00M | -30087.00M | 2213.00M | 1548.00M |
| Change to liabilities | - | - | - | 8907.00M | 5918.00M |
| Total cashflows from investing activities | - | - | - | -61567.00M | -66247.00M |
| Net borrowings | 15162.00M | 140258.00M | - | -41786.00M | -8996.00M |
| Total cash from financing activities | - | - | - | -123055.00M | -60387.00M |
| Change to operating activities | - | - | - | -7622.00M | 4789.00M |
| Net income | 70272.00M | 87121.00M | 94065.00M | 75725.00M | 59416.00M |
| Change in cash | -6760.00M | 38759.00M | -18677.00M | -30155.00M | 39909.00M |
| Begin period cash flow | 171537.00M | 132777.00M | 151454.00M | 181609.00M | 141701.00M |
| End period cash flow | 164776.00M | 171537.00M | 132777.00M | 151454.00M | 181609.00M |
| Total cash from operating activities | 209898.00M | 168074.00M | 117640.00M | 145576.00M | 165650.00M |
| Depreciation | 86461.00M | 78298.00M | 71820.00M | 66234.00M | 63045.00M |
| Other cashflows from investing activities | - | - | - | -1966.00M | 2470.00M |
| Dividends paid | 39136.00M | 38406.00M | -31630.00M | -27273.00M | -17526.00M |
| Change to inventory | -9547.00M | 4346.00M | -41613.00M | -17914.00M | -8090.00M |
| Change to account receivables | - | - | - | 6057.00M | 21580.00M |
| Sale purchase of stock | -90695.00M | -91341.00M | -30022.00M | -40041.00M | -7.00M |
| Other cashflows from financing activities | - | - | - | -13889.00M | -33858.00M |
| Change to netincome | - | - | - | -32558.00M | -19912.00M |
| Capital expenditures | 95090.00M | 72022.00M | 73046.00M | 73842.00M | 76889.00M |
| Change in working capital | 4114.00M | 6838.00M | -45247.00M | -17521.00M | 16536.00M |
| Other non cash items | -3528.00M | 1914.00M | 6377.00M | 8929.00M | 1692.00M |
| Free cash flow | 114808.00M | 96052.00M | 44594.00M | 64857.00M | 79613.00M |
Sector: Consumer Defensive Industry: Packaged Foods
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| AJINF Ajinomoto Co. Inc |
- -% |
33.19 | 123.75 | 32.26 | 0.02 | 5.97 | 3.11 | 22.61 |
| NSRGF Nestle SA |
-0.36 0.37% |
98.24 | 26.86 | 18.76 | 3.13 | 7.10 | 3.81 | 21.70 |
| NSRGY Nestle SA ADR |
0.30 0.30% |
100.06 | 26.82 | 18.66 | 3.18 | 7.07 | 3.81 | 21.70 |
| DANOY Danone PK |
0.30 2.13% |
14.41 | 24.23 | 17.64 | 1.88 | 2.57 | 1.88 | 11.70 |
| GPDNF Danone S.A |
- -% |
69.76 | 20.30 | 14.75 | 1.65 | 2.24 | 1.76 | 10.92 |
Ajinomoto Co., Inc. engages in the seasonings and foods, frozen foods, and healthcare and other businesses in Japan and internationally. The Seasonings and Foods segment offers sauces and seasoning products under the AJI-NO-MOTO, HON-DASHI, Cook Do, Ajinomoto KK Consommé, Pure Select Mayonnaise, Ros Dee, Masako, Aji-ngon, Sazón, Sajiku, and CRISPY FRY names. This segment also provides instant noodles under the Knorr Cup Soup and YumYum names; coffee beverages under the Birdy and Blendy brands; powdered drink under the Birdy 3in1 name; MAXIM brand products; A Little Luxury Coffee Shop brand products and various gifts, office drinks, cup vending machines, and tea dispensers, etc. The Frozen Foods segment offers Gyoza dumplings, rice dishes, noodles, sweets, shumai, processed chicken, and other products. The Healthcare and Other segment provides amino acids for applications in various industries, such as pharmaceuticals and foods; contract development and manufacturing services for pharmaceutical intermediates and active ingredients, and sterile preparations. This segment also offers Ajinomoto Build-up Film, an interlayer insulating material for semiconductor packages; functional materials under the Plainset names; AFTINNOVA, such as activated carbon, release paper, etc.; feed amino acids, sports nutrition under the brand Aminovital, personal care materials under the brand Amisoft, amino acid-based makeup oil under the brand Eldew, and powder under the brand Amihope, medical foods, and agricultural services, etc. Ajinomoto Co., Inc. was founded in 1909 and is headquartered in Tokyo, Japan.
| Name | Title | Year Born |
|---|---|---|
| Mr. George Gwinnett Bompas | Gen. Mang. of AminoScience | NA |
| Mr. Taro Fujie | Representative Exec. Officer, Pres, CEO & Director | 1961 |
| Mr. Saburosuke Suzuki II | Founder | NA |
| Mr. Tetsuya Nakano | Exec. Officer, VP and In Charge of Fin. & Investor Relations | NA |
| Watanabe Yumiko | Associate Gen. Mang. of IR | NA |
| Ms. Chika Morishima | Exec. Officer and In charge of Sustainability & Communications | NA |
| Ms. Chiaki Nosaka | Exec. Officer, SVP, In charge of Diversity & HR and Internal Director | 1960 |
| Hiroshi Motoyama | Corp. VP | NA |
| Mr. Jiro Sakamoto | Exec Officer, VP, GM of NA Div and Pres of Ajinomoto Health & Nutrition NA Inc. | NA |
| Mr. Takayuki Koda | Exec. Officer, Sr. VP, Chief Digital Officer & Chief Transformation Officer | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.